Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Housing Mice At Sub-Thermoneutral Temperatures Influences Severity Of Gvhd In Mouse Models

Kathleen M Kokolus, MS, Nicholas D Leigh, BS, George Chen, MD, Philip L. McCarthy, Jr., MD, Xuefang Cao, PhD, Elizabeth A Repasky, PhD

Blood (2013) 122 (21): 5422.

https://doi.org/10.1182/blood.V122.21.5422.5422

Published: 2013

Journal Articles

Perforin Is Important For Both CD4+ and CD8+ T Cell-Mediated Graft-Versus-Tumor Effect But Plays Differential Roles In CD4+ and CD8+ T Cell Expansion After Allogeneic Transplantation

Nicholas Leigh, Guanglin Bian, PhD, Wei Du, George L. Chen, MD, Hong Liu, MD, PhD, Philip L. McCarthy, Jr., MD, Xuefang Cao, PhD

Blood (2013) 122 (21): 3255.

https://doi.org/10.1182/blood.V122.21.3255.3255

Published: 2013

Journal Articles

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Theresa Hahn, PhD, Yali Zhang, MPH, Bruno Paiva, George L. Chen, MD, Paul K. Wallace, MS, PhD, Philip L. McCarthy, Jr., MD

Blood (2013) 122 (21): 3348.

https://doi.org/10.1182/blood.V122.21.3348.3348

Published: 2013

Journal Articles

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Marcelo C. Pasquini, MD, MS, Brent R. Logan, PhD, Vincent T Ho, MD, Philip L. McCarthy, Jr., MD, Kenneth R. Cooke, MD, J. Douglas Rizzo, MD, Xiaochun Zhu, MS, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 814.

https://doi.org/10.1182/blood.V120.21.814.814

Published: 2012

Journal Articles

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

Mohamed L. Sorror, MD, MSc, Brent R. Logan, PhD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Kenneth R. Cooke, MD, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Barry Storer, PhD, Marcelo C Pasquini, MD, MS

Blood (2012) 120 (21): 733.

https://doi.org/10.1182/blood.V120.21.733.733

Published: 2012

Journal Articles

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Monica S Thakar, MD, Brent R. Logan, PhD, Marcelo C. Pasquini, MD, MS, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Kenneth R. Cooke, MD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 737.

https://doi.org/10.1182/blood.V120.21.737.737

Published: 2012

Journal Articles

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Sophia Francis, Theresa Hahn, PhD, Yali Zhang, MPH, Nikolaos Almyroudis, MD, George L. Chen, MD, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Brahm H Segal, MD, Philip L. McCarthy, Jr., MD

Blood (2012) 120 (21): 4141.

https://doi.org/10.1182/blood.V120.21.4141.4141

Published: 2012

Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 4570.

https://doi.org/10.1182/blood.V118.21.4570.4570

Published: 2011

Journal Articles

A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Hillard M. Lazarus, MD FACP, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 499.

https://doi.org/10.1182/blood.V118.21.499.499

Published: 2011

Journal Articles

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

George L. Chen, MD, Yali Zhang, MPH, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3038.

https://doi.org/10.1182/blood.V118.21.3038.3038

Published: 2011

Journal Articles

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hong Liu, MD, PhD, Yali Zhang, MPH, Theresa Hahn, PhD, Julie Thomas, DO, Meir Wetzler, MD, Eunice S. Wang, MD, Lise Hernandez, MPH, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3096.

https://doi.org/10.1182/blood.V118.21.3096.3096

Published: 2011

Journal Articles

Clinical and Genetic Factors Underlying Acute Bone Mineral Density Loss by 100 Days after Blood and Marrow Transplantation: A Potential Early Regimen-Related Complication

Theresa Hahn, PhD, Song Yao, Shannon Smiley, Kathleen West, Minoo Battiwalla, Dominick Lamonica, Philip L McCarthy, Jr

Blood (2008) 112 (11): 52.

https://doi.org/10.1182/blood.V112.11.52.52

Published: 2008

Journal Articles

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Shannon L Smiley, MD, Theresa Hahn, PhD, Wei Tan, MS, Gregory Wilding, PhD, Minoo Battiwalla, MD, Philip L. McCarthy, Jr., MD

Blood (2008) 112 (11): 2176.

https://doi.org/10.1182/blood.V112.11.2176.2176

Published: 2008

Journal Articles

Glutathione- S -Transferase M1 ( GSTM1 ) and T1 ( GSTT1 ) Deletion Polymorphisms Predict Regimen-Related Toxicity after Autologous and Allogeneic Blood and Marrow Transplantation (BMT).

Theresa Hahn, PhD, Eugenia Zhelnova, MD, PhD, Irina Demidova, MD, Valery Savchenko, MD, Christine B. Ambrosone, PhD, Philip L. McCarthy, Jr., MD

Blood (2007) 110 (11): 1982.

https://doi.org/10.1182/blood.V110.11.1982.1982

Published: 2007

Journal Articles

Risk Factors for Acute Graft-Versus-Host Disease (GvHD) after Related Donor HLA-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Adult Leukemia: Identification of Modifiable and Non-Modifiable Factors. A CIBMTR Study.

Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD, Dan Wang, MS, Mei-Jie Zhang, PhD, Mukta Aurora, MD, MS, Steven Pavletic, MD, A. John Barrett, MD, Olle Ringden, MD, PhD

Blood (2007) 110 (11): 1069.

https://doi.org/10.1182/blood.V110.11.1069.1069

Published: 2007

Journal Articles

Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence

Minoo Battiwalla, Theresa Hahn, Marija Radovic, Hilary Roy, Afrin Wahab, Eileen Duman, Rajinder Bajwa, Swaminathan Padmanabhan, Joanne Becker, A. John Barrett, Philip L. McCarthy, Jr

Blood (2006) 107 (5): 1970–1973.

https://doi.org/10.1182/blood-2005-05-1958

Published: 2006

Journal Articles

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.

Lauren M. Dunford, BA, David M. Roy, Theresa Hahn, PhD, Karen Brown, MS, FNP-C, ONP, Pamela Paplham, MS, FNP, ONP, Dominick M. Lamonica, MD, Minoo Battiwalla, MD, MS, Swaminathan Padmanabhan, MD, Philip L. McCarthy, Jr., MD

Blood (2005) 106 (11): 2011.

https://doi.org/10.1182/blood.V106.11.2011.2011

Published: 2005

Journal Articles

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Stephanie J. Lee, David Zahrieh, Edward Agura, Margaret L. MacMillan, Richard T. Maziarz, Philip L. McCarthy, Jr, Vincent T. Ho, Corey Cutler, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

Blood (2004) 104 (5): 1559–1564.

https://doi.org/10.1182/blood-2004-03-0854

Published: 2004

Journal Articles

Allogeneic Bone Marrow Transplantation for Low-Grade Lymphoma

Koen van Besien, Kathleen A. Sobocinski, Philip A. Rowlings, Sandra C. Murphy, James O. Armitage, Michael R. Bishop, Ok-kyong Chaekal, Robert Peter Gale, John P. Klein, Hillard M. Lazarus, Philip L. McCarthy, Jr, John M.M. Raemaekers, Josy Reiffers, Gordon L. Phillips, Anton V.M.B. Schattenberg, Leo F. Verdonck, Julie M. Vose, Mary M. Horowitz

Blood (1998) 92 (5): 1832–1836.

https://doi.org/10.1182/blood.V92.5.1832

Published: 1998

NARROW

Housing Mice At Sub-Thermoneutral Temperatures Influences Severity Of Gvhd In Mouse Models

Perforin Is Important For Both CD4+ and CD8+ T Cell-Mediated Graft-Versus-Tumor Effect But Plays Differential Roles In CD4+ and CD8+ T Cell Expansion After Allogeneic Transplantation

Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Clinical and Genetic Factors Underlying Acute Bone Mineral Density Loss by 100 Days after Blood and Marrow Transplantation: A Potential Early Regimen-Related Complication

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Glutathione- S -Transferase M1 ( GSTM1 ) and T1 ( GSTT1 ) Deletion Polymorphisms Predict Regimen-Related Toxicity after Autologous and Allogeneic Blood and Marrow Transplantation (BMT).

Risk Factors for Acute Graft-Versus-Host Disease (GvHD) after Related Donor HLA-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Adult Leukemia: Identification of Modifiable and Non-Modifiable Factors. A CIBMTR Study.

Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Allogeneic Bone Marrow Transplantation for Low-Grade Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only